Literature DB >> 27917078

Global Elimination of Hepatitis C Virus.

John W Ward1.   

Abstract

Entities:  

Year:  2016        PMID： 27917078      PMCID： PMC5114506     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  7 in total

1.  Cost-effectiveness of strategies for testing current hepatitis C virus infection.

Authors:  Michael K Chapko; D Robert Dufour; Rikita I Hatia; Jan Drobeniuc; John W Ward; Chong-Gee Teo
Journal:  Hepatology       Date:  2015-08-25       Impact factor: 17.425

2.  Identification and Clinical Management of Persons with Chronic Hepatitis C Virus Infection - Cherokee Nation, 2012-2015.

Authors:  Jorge Mera; Claudia Vellozzi; Susan Hariri; Hélène Carabin; Douglas A Drevets; Anna Miller; Brigg Reilley; Whitney Essex; David Gahn; Lisa Lyons; Jessica Leston; John W Ward
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-05-13       Impact factor: 17.586

3.  The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus.

Authors:  David B Rein; John S Wittenborn; Bryce D Smith; Danielle K Liffmann; John W Ward
Journal:  Clin Infect Dis       Date:  2015-03-16       Impact factor: 9.079

4.  The Burden of Hepatitis C Infection-Related Liver Fibrosis in the United States.

Authors:  R Monina Klevens; Lauren Canary; Xiaohua Huang; Maxine M Denniston; Anthony E Yeo; Rick L Pesano; John W Ward; Scott Holmberg
Journal:  Clin Infect Dis       Date:  2016-08-09       Impact factor: 9.079

5.  Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention.

Authors:  Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; John W Ward
Journal:  Ann Intern Med       Date:  2012-12-04       Impact factor: 25.391

6.  Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010.

Authors:  Maxine M Denniston; Ruth B Jiles; Jan Drobeniuc; R Monina Klevens; John W Ward; Geraldine M McQuillan; Scott D Holmberg
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

7.  Launch of a Nationwide Hepatitis C Elimination Program--Georgia, April 2015.

Authors:  Kiren Mitruka; Tengiz Tsertsvadze; Maia Butsashvili; Amiran Gamkrelidze; Paata Sabelashvili; Ekaterine Adamia; Mari Chokheli; Jan Drobeniuc; Liesl Hagan; Aaron M Harris; Tea Jiqia; Ana Kasradze; Stephen Ko; Vakhtang Qerashvili; Lali Sharvadze; Irina Tskhomelidze; Valeri Kvaratskhelia; Juliette Morgan; John W Ward; Francisco Averhoff
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-07-24       Impact factor: 17.586
  7 in total
  3 in total

1.  Cost-effectiveness of Direct Antiviral Agents for Hepatitis C Virus Infection and a Combined Intervention of Syringe Access and Medication-assisted Therapy for Opioid Use Disorders in an Injection Drug Use Population.

Authors:  Elizabeth R Stevens; Kimberly A Nucifora; Holly Hagan; Ashly E Jordan; Jennifer Uyei; Bilal Khan; Kirk Dombrowski; Don des Jarlais; R Scott Braithwaite
Journal:  Clin Infect Dis       Date:  2020-06-10       Impact factor: 9.079

2.  'Sussing that doctor out.' Experiences and perspectives of people affected by hepatitis C regarding engagement with private general practitioners in South Australia: a qualitative study.

Authors:  Jane Scarborough; Emma Ruth Miller; Paul Aylward; Jaklin Eliott
Journal:  BMC Fam Pract       Date:  2017-11-29       Impact factor: 2.497

3.  Impact of the Covid-19 pandemic on the elimination of hepatitis C virus in Duhok, Kurdistan, Iraq: A retrospective cross-sectional study.

Authors:  Nawfal R Hussein; Shameran Daniel; Shahram A Mirkhan; Zana Sidiq M Saleem; Dildar H Musa; Nashwan Ibrahim; Ibrahim A Naqid
Journal:  J Family Med Prim Care       Date:  2020-12-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.